PUBLISHER: Polaris Market Research | PRODUCT CODE: 1124857
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1124857
Alzheimer's Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Drug Class (Cholinesterase Inhibitors, NMDA Receptor Antagonists, and Manufactured Combination); By Distribution Channel; By Region; Segment Forecast, 2022 - 2030
The global alzheimer's therapeutics market size is expected to reach USD 14.20 billion by 2030, according to a new study by Polaris Market Research. The report "Alzheimer's Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Drug Class (Cholinesterase Inhibitors, NMDA Receptor Antagonists, and Manufactured Combination); By Distribution Channel; By Region; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Alzheimer's disease is a degenerative neurological condition where memory loss and cognitive impairment are brought on by the death of brain cells. As the brain shrinks, intellectual, social, and behavioral abilities gradually deteriorate. It is the most frequent cause of dementia.
Alzheimer's accounts for 60-70% of all cases of dementia, making it the most prevalent type. Government and non-government organizations are investing extensively in the development of diagnostics and therapies for the disease as a result of the rising prevalence of the disease worldwide, which could help the industry grow. According to the World Health Organization, the economic cost burden is huge, ranging from USD 1.3 trillion to 2.8 trillion by 2030.
The patient's family, society, and the economy are all severely impacted by AD. Both the illness and its mechanism are complex. Given the increase in AD incidence globally, certain research has shown the necessity to create an effective therapy. Memantine and acetylcholinesterase inhibitors are the only medications used to treat this condition, despite the fact that it has been studied for more than a century.
The industry for this disease therapeutics would expand as R&D investments by biopharmaceutical firms increased. Additionally, the development of novel therapies to treat, sluggish, and prevent disease, as well as early Alzheimer's disease diagnosis, will create prospects for the worldwide market for disease therapeutics.
The industry is expanding as a result of rising healthcare awareness and new Alzheimer's disease diagnostic technologies. Due to the rising frequency of disease, there has been a rise in the use of medicines for the condition recently. The demand for such disease medicines is expanding as a result of an aging population, rising healthcare costs, and greater government spending.
Alzheimer's Therapeutics Market Report Highlights
Cholinesterase Inhibitors segment is anticipated to grow at a lucrative CAGR over the forecast period owing to the frequently recommended to treat symptoms linked to memory, thinking, language, judgment, and other application
Retail Pharmacies segment is expected to hold the significant revenue share over the forecast period due to the easy access and availability of drugs and therapies for Alzheimer's treatment.
North America is expected to grow at a significant CAGR rate over the projected period on account of the rapidly increasing ageing population, significant investment in research and development activities, and the introduction of new products
The global players include Cipla Ltd., Torrent Pharmaceuticals, Unichem laboratories, Lannett Inc., Janssen Pharmaceuticals, Novartis, Zydus Lifesciences, Sun Pharmaceutical, Dr. Reddy's Laboratories, and Aurobindo.
Polaris Market Research has segmented the alzheimer's therapeutics market report based on drug class, distribution channel, and region:
Alzheimers Therapeutics, Drug Class Outlook (Revenue - USD Billion, 2018 - 2030)
Cholinesterase Inhibitors
NMDA Receptor Antagonists
Manufactured Combination
Alzheimers Therapeutics, Distribution Channel Outlook (Revenue - USD Billion, 2018 - 2030)
Retail Pharmacies
Hospital Pharmacies
Online Pharamcies
Alzheimers Therapeutics, Regional Outlook (Revenue - USD Billion, 2018 - 2030)
North America
U.S
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Latin America
Argentina
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Alzheimer's Therapeutics Market Insights
- 4.1. Alzheimer's Therapeutics Market - Industry Snapshot
- 4.2. Alzheimer's Therapeutics Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increase in government funding and initiatives
- 4.2.1.2. Increase in Awareness programs
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Presence of stringent regulatory framework
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTLE Analysis
- 4.5. Alzheimer's Therapeutics Industry trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Alzheimer's Therapeutics Market, by Drug Class
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Alzheimer's Therapeutics, by Drug Class, 2018 - 2030 (USD Billion)
- 5.3. Cholinesterase Inhibitors
- 5.3.1. Global Alzheimer's Therapeutics Market, by Cholinesterase Inhibitors, by Region, 2018 - 2030 (USD Billion)
- 5.4. NMDA Receptor Antagonists
- 5.4.1. Global Alzheimer's Therapeutics Market, by NMDA Receptor Antagonists, by Region, 2018 - 2030 (USD Billion)
- 5.5. Manufactured Combination
- 5.5.1. Global Alzheimer's Therapeutics Market, by Manufactured Combination, by Region, 2018 - 2030 (USD Billion)
6. Global Alzheimer's Therapeutics Market, by Distribution Channel
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 6.3. Hospital Pharmacies
- 6.3.1. Global Alzheimer's Therapeutics Market, by Hospital Pharmacies, by Region, 2018 - 2030 (USD Billion)
- 6.4. Online Pharmacies
- 6.4.1. Global Alzheimer's Therapeutics Market, by Online Pharmacies, by Region, 2018 - 2030 (USD Billion)
- 6.5. Retail Pharmacies
- 6.5.1. Global Alzheimer's Therapeutics Market, by Retail Pharmacies, by Region, 2018 - 2030 (USD Billion)
7. Global Alzheimer's Therapeutics Market, by Geography
- 7.1. Key findings
- 7.2. Introduction
- 7.2.1. Alzheimer's Therapeutics Market Assessment, By Geography, 2018 - 2030 (USD Billion)
- 7.3. Alzheimer's Therapeutics Market - North America
- 7.3.1. North America: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 7.3.2. North America: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- 7.3.3. Alzheimer's Therapeutics Market - U.S.
- 7.3.3.1. U.S.: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 7.3.3.2. U.S.: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- 7.3.4. Alzheimer's Therapeutics Market - Canada
- 7.3.4.1. Canada: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 7.3.4.2. Canada: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- 7.4. Alzheimer's Therapeutics Market - Europe
- 7.4.1. Europe: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 7.4.2. Europe: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- 7.4.3. Alzheimer's Therapeutics Market - UK
- 7.4.3.1. UK: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 7.4.3.2. UK: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- 7.4.4. Alzheimer's Therapeutics Market - France
- 7.4.4.1. France: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 7.4.4.2. France: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- 7.4.5. Alzheimer's Therapeutics Market - Germany
- 7.4.5.1. Germany: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 7.4.5.2. Germany: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- 7.4.6. Alzheimer's Therapeutics Market - Italy
- 7.4.6.1. Italy: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 7.4.6.2. Italy: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- 7.4.7. Alzheimer's Therapeutics Market - Spain
- 7.4.7.1. Spain: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 7.4.7.2. Spain: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- 7.4.8. Alzheimer's Therapeutics Market - Netherlands
- 7.4.8.1. Netherlands: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 7.4.8.2. Netherlands: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- 7.4.9. Alzheimer's Therapeutics Market - Russia
- 7.4.9.1. Russia: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 7.4.9.2. Russia: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- 7.5. Alzheimer's Therapeutics Market - Asia Pacific
- 7.5.1. Asia Pacific: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 7.5.2. Asia Pacific: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- 7.5.3. Alzheimer's Therapeutics Market - China
- 7.5.3.1. China: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 7.5.3.2. China: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- 7.5.4. Alzheimer's Therapeutics Market - India
- 7.5.4.1. India: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 7.5.4.2. India: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- 7.5.5. Alzheimer's Therapeutics Market - Malaysia
- 7.5.5.1. Malaysia: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 7.5.5.2. Malaysia: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- 7.5.6. Alzheimer's Therapeutics Market - Japan
- 7.5.6.1. Japan: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 7.5.6.2. Japan: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- 7.5.7. Alzheimer's Therapeutics Market - Indonesia
- 7.5.7.1. Indonesia: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 7.5.7.2. Indonesia: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- 7.5.8. Alzheimer's Therapeutics Market - South Korea
- 7.5.8.1. South Korea: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 7.5.8.2. South Korea: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- 7.6. Alzheimer's Therapeutics Market - Middle East & Africa
- 7.6.1. Middle East & Africa: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 7.6.2. Middle East & Africa: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- 7.6.3. Alzheimer's Therapeutics Market - Saudi Arabia
- 7.6.3.1. Saudi Arabia: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 7.6.3.2. Saudi Arabia: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- 7.6.4. Alzheimer's Therapeutics Market - UAE
- 7.6.4.1. UAE: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 7.6.4.2. UAE: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- 7.6.5. Alzheimer's Therapeutics Market - Israel
- 7.6.5.1. Israel: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 7.6.5.2. Israel: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- 7.6.6. Alzheimer's Therapeutics Market - South Africa
- 7.6.6.1. South Africa: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 7.6.6.2. South Africa: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- 7.7. Alzheimer's Therapeutics Market - Latin America
- 7.7.1. Latin America: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 7.7.2. Latin America: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- 7.7.3. Alzheimer's Therapeutics Market - Mexico
- 7.7.3.1. Mexico: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 7.7.3.2. Mexico: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- 7.7.4. Alzheimer's Therapeutics Market - Brazil
- 7.7.4.1. Brazil: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 7.7.4.2. Brazil: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- 7.7.5. Alzheimer's Therapeutics Market - Argentina
- 7.7.5.1. Argentina: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 7.7.5.2. Argentina: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
8. Competitive Landscape
- 8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
- 8.2. Partnerships/Collaborations/Agreements/Exhibitions
9. Company Profiles
- 9.1. Teva Pharmaceuticals
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
- 9.2. Eisai Co.
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
- 9.3. AbbVie, Inc
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
- 9.4. Amneal Pharmaceuticals
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
- 9.5. Macleods Pharmaceuticals
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
- 9.6. Viatris Inc
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
- 9.7. Lupin
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
- 9.8. Cipla
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
- 9.9. Torrent Pharmaceuticals
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
- 9.10. Unichem Laboratories
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
- 9.11. Lannett
- 9.11.1. Company Overview
- 9.11.2. Financial Performance
- 9.11.3. Product Benchmarking
- 9.11.4. Recent Development
- 9.12. Janssen Pharmaceuticals
- 9.12.1. Company Overview
- 9.12.2. Financial Performance
- 9.12.3. Product Benchmarking
- 9.12.4. Recent Development
- 9.13. Novartis
- 9.13.1. Company Overview
- 9.13.2. Financial Performance
- 9.13.3. Product Benchmarking
- 9.13.4. Recent Development
- 9.14. Zydus Lifesciences
- 9.14.1. Company Overview
- 9.14.2. Financial Performance
- 9.14.3. Product Benchmarking
- 9.14.4. Recent Development
- 9.15. Sun Pharmaceutical
- 9.15.1. Company Overview
- 9.15.2. Financial Performance
- 9.15.3. Product Benchmarking
- 9.15.4. Recent Development
- 9.16. Dr. Reddy's Laboratories
- 9.16.1. Company Overview
- 9.16.2. Financial Performance
- 9.16.3. Product Benchmarking
- 9.16.4. Recent Development
- 9.17. Aurobindo
- 9.17.1. Company Overview
- 9.17.2. Financial Performance
- 9.17.3. Product Benchmarking
- 9.17.4. Recent Development
List of Tables
- Table 1 Global Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- Table 2 Global Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 3 Alzheimer's Therapeutics Market Assessment, By Geography, 2018 - 2030 (USD Billion)
- Table 4 North America: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- Table 5 North America: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 6 U.S.: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- Table 7 U.S.: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 8 Canada: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- Table 9 Canada: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 10 Europe: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- Table 11 Europe: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 12 UK: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- Table 13 UK: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 14 France: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- Table 15 France: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 16 Germany: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- Table 17 Germany: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 18 Italy: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- Table 19 Italy: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 20 Spain: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- Table 21 Spain: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 22 Netherlands: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- Table 23 Netherlands: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 24 Russia: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- Table 25 Russia: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 26 Asia Pacific: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- Table 27 Asia Pacific: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 28 China: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- Table 29 China: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 30 India: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- Table 31 India: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 32 Malaysia: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- Table 33 Malaysia: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 34 Japan: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- Table 35 Japan: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 36 Indonesia: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- Table 37 Indonesia: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 38 South Korea: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- Table 39 South Korea: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 40 Middle East & Africa: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- Table 41 Middle East & Africa: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 42 Saudi Arabia: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- Table 43 Saudi Arabia: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 44 UAE: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- Table 45 UAE: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 46 Israel: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- Table 47 Israel: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 48 South Africa: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- Table 49 South Africa: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 50 Latin America: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- Table 51 Latin America: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 52 Mexico: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- Table 53 Mexico: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 54 Brazil: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- Table 55 Brazil: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 56 Argentina: Alzheimer's Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- Table 57 Argentina: Alzheimer's Therapeutics Market, by Drug Class, 2018 - 2030 (USD Billion)
List of Figures
Figure 1 Global Alzheimer's Therapeutics Market, 2018 - 2030 (USD Billion)
Figure 2 Integrated Ecosystem
Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
Figure 4 Market by Geography
Figure 5 Porter's Five Forces
Figure 6 Market by Distribution Channel
Figure 7 Global Alzheimer's Therapeutics Market, by Distribution Channel, 2021 & 2030 (USD Billion)
Figure 8 Market by Drug Class
Figure 9 Global Alzheimer's Therapeutics Market, by Drug Class, 2021 & 2030 (USD Billion)
Figure 10 Alzheimer's Therapeutics Market Assessment, By Geography, 2018 - 2030 (USD Billion)
Figure 11 Strategic Analysis - Alzheimer's Therapeutics Market
